Impaired Function of Macrophage Fcγ Receptors in End-Stage Renal Disease

New England Journal of Medicine

Volumn 322, Issue 11, 1990, Pages 717-722

  Ruiz, Pedro ^a   Gomez, Francisco ^a   Schreiber, Alan D ^b  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFECTION RISK; KIDNEY DISEASE; KIDNEY FAILURE; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HUMAN; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INFECTION; KIDNEY FAILURE, CHRONIC; MACROPHAGES; MALE; MIDDLE AGE; NUTRITIONAL STATUS; RECEPTORS, FC; RENAL DIALYSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025268691     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199003153221102     Document Type: Article

References (40)

1. Frank MM, Lawley TJ, Hamburger MI, Brown EJ. Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann Intern Med 1983; 98: 206–18.
2. Kimberly RP, Ralph P. Endocytosis by the mononuclear phagocyte system and autoimmune disease. Am J Med 1983; 74: 481–93.
3. Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980; 93: 597–613.
4. Lahnborg G, Berghem L, Ahlgren T, Groth CG, Lundgren G, Tillegard A. Reticuloendothelial function in human renal allograft recipients. Transplantation 1979; 28: 111–5.
5. Drivas G, Rethymniotakis N, Kalos A, Kaliakmanis N, Melissinos K. Reticuloendothelial phagocytosis in patients with chronic renal failure. Invest Urol 1979; 17: 241–3.
6. Keane WF, Raij LR. Host defenses and infectious complications in maintenance hemodialysis patients. In: Drukker W, Parson FM, Maher JF, eds. Replacement of renal function by dialysis. 2nd ed. Boston: Martinus Nijhoff, 1983:646–58.
7. Gaither TA, Alling DW, Frank MM. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol 1974; 113: 574—83.
8. Zubler RH, Lamber P-H. The 125I–C1q binding test for the detection of soluble immune complexes. In: Bloom BR, David JR, eds. In vitro methods in cell-mediated and tumor immunity. New York: Academic Press, 1976: 565–72.
9. Boyko WJ, Pratt R, Wass H. Functional hyposplenism: a diagnostic clue in amyloidosis: report of six cases. Am J Clin Pathol 1982; 77: 745–8.
10. Schreiber AD, Frank MM. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites. J Clin Invest 1972; 51: 575–82.
11. Friedman D, Nettl F, Schreiber AD. Effect of estradiol and steroid analogues on the clearance of immunoglobulin G-coated erythrocytes. J Clin Invest 1985; 75: 162–7.
12. Cines DB, Schreiber AD. Immune thrombocytopenia: use of a Coombs antiglobulin test to detect IgG and C3 on platelets. N Engl J Med 1979; 300: 106–11.
13. Gomez F, Kelley M, Rossman MD, Dauber J, Schreiber AD. Macrophage recognition of complement-coated lymphoblastoid cells. J Reticuloendothel Soc 1982; 31: 241–9.
14. Schreiber AD, Parson J, McDermott P, Cooper RA. Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest 1975; 56: 1189–97.
15. Blumenkrantz MJ, Kopple JD, Gutman RA, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980; 33: 1567–85.
16. Harvey KB, Blumenkrantz MJ, Levine SE, Blackburn GL. nutritional assessment and treatment of chronic renal failure. Am J Clin Nutr 1980; 33: 1586–97.
17. Blackburn GL, Bistrian BR, Maini BJ, Schlamm HT, Smith MF. nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr 1977; 1: 11–22.
18. Mattern WD, Hak LJ, Lamanna RW, Teasle KM, Laffell MS. Malnutrition, altered immune function, and the risk of infection in maintenance hemodialysis patients. Am J Kidney Dis 1982; 1: 206–18.
19. Casciato DA, McAdam LP, Kopple JD, et al. Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy. Nephron 1984; 38: 9–16.
20. Dobbelstein H, Korner WF, Mempel W, Grosse-Wilde H, Edel HH. Vitamin B6 deficiency in uremia and its implications for the depression of immune responses. Kidney Int 1974; 5: 233–9.
21. Maher JF, Freeman RB, Schreiner GE. Hemodialysis for chronic renal failure. II. Biochemical and clinical aspects. Ann Intern Med 1965; 62: 535–50.
22. Goldblum SE, Van Epps DE, Reed WP. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis. J Clin Invest 1979; 64: 255–64.
23. Friedman EA, Beyer MM, Hirsch SR, Schiffman G. Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes. JAMA 1980; 244: 2310–1.
24. Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979; 300: 518–23.
25. Parris TM, Kimberly RP, Inman RD, McDougal JS, Gibofsky A, Christian CL. Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann Intern Med 1982; 97: 526–32.
26. Klinman AM, Steinberg AD. Systemic lupus erythematosus and overlap syndromes. In: Samter M, ed. Immunological diseases. 4th ed. Boston: Little, Brown, 1988:1335–64.
27. Anderson CL, Looney RJ. Human leukocyte IgG Fc receptors. Immunol Today 1986; 7: 264–6.
28. Chien P, Pixley RA, Stumpo LG, Colman RW, Schreiber AD. Modulation of human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor. J Clin Invest 1988; 82: 1554–9.
29. Gomez F, Chien P, King M, et al. Monocyte Fcγ receptor recognition of cell-bound and aggregated IgG. Blood 1989; 74: 1058–65.
30. Schreiber AD, Chien P, Tomaski A, Cines DB. Effect of danazol in immune thrombocytopenic purpura. N Engl J Med 1987; 316: 503–8.
31. Clarkson SB, Bussel JB, Kimberly RP, Valinsky JE, Nachman RL, Unkeless JC. Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody. N Engl J Med 1986; 314: 1236–9.
32. Atkin-Thor E, Goddard BW, O'Nion J, Stephen RL, Kolff WJ. Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 1978; 31: 1948–51.
33. Tsukamoto Y, Iwanami S, Marumo F. Disturbances of trace element concentrations in plasma of patients with chronic renal failure. Nephron 1980; 26: 174–9.
34. Holmes KL, Palfree RG, Hammerling U, Morse HC III. Alleles of the Ly-17 alloantigen define polymorphisms of the murine IgG Fc receptor. Proc Natl Acad Sci U S A 1985; 82: 7706–10.
35. Lawley TJ, Hall RP, Fauci AS, Katz SI, Hamburger MI, Frank MM. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. N Engl J Med 1981; 304: 185–92.
36. Kimberly RP, Gibofsky A, Salmon JE, Fotino M. Impaired Fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults. J Exp Med 1983; 157: 1698–703.
37. Bender BS, Frank MM, Lawley TJ, Smith WJ, Brickman CM, Quinn TC. Defective reticuloendothelial system Fc-receptor function in patients with the acquired immunodeficiency syndrome. J Infect Dis 1985; 152: 409–12.
38. Smith PD, Ohura K, Masur H, Lane HC, Fauci AS, Wahl SM. Monocyte function in the acquired immune deficiency syndrome: defective chemotaxis. J Clin Invest 1984; 74: 2121–8.
39. Schreiber AD, Nettl FM, Sanders MC, et al. Effect of endogenous and synthetic sex steroids on the clearance of antibody-coated cells. J Immunol 1988; 141: 2959–66.
40. Rossman MD, Chen E, Chien P, Schreiber AD. Modulation of Fcγ receptors on the human macrophage cell line U-937. Cell Immunol 1989; 120: 174–87.